Disclosure under SEBI Takeover Regulations

ASHISH DANDEKAR 9th Floor, Concorde Apts. Bullock Road, Bandstand, Bandra (W), Mumbai – 400050 April 10, 2026 To, To, To, The Manager, BSE Limited, The Audit Committee, Listing Department, 25, P. J. Towers, Camlin Fine Sciences Ltd., National Stock Exchange of India Ltd., Dalal Street, 2nd floor, In G.S. Point, CST Exchange Plaza, Mumbai – 400 001 Road, Kalina, Santacruz (East), Bandra Kurla Complex, Ref: Scrip Code: 532834 Mumbai 400 098. Bandra (East), Mumbai- 400051 Ref: Symbol: CAMLINFINE || Series: EQ Dear Sir/Madam, Sub: Declaration pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (“Takeover Regulations”) Pursuant to Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, I, Ashish Dandekar, hereby declare that we, the following named Promoter and Promoter Group of Camlin Fine Sciences Limited (“the Company”), have not made any encumbrance on the shares of the Company held by us, directly or indirectly, other than those already disclosed during the financial year ended March 31, 2026. Details of Entity/Person on who's behalf the declaration is being submitted: Name of Entity Person Category Ashish S Dandekar Promoter Radha Pandit Promoter Group Anand Y Pandit Promoter Group Anagha Dandekar Promoter Vibha Agencies Pvt Ltd Promoter Camart Finance Ltd Promoter Cafco Consultants Ltd Promoter MK Falcon Agrotech Pvt Ltd Promoter Kindly take the same on record and disseminate the same on your website. Thanking you, Yours truly, Ashish S. Dandekar On behalf of Promoter Group of Camlin Fine Sciences Limited Place: Mumbai The Company Secretary, Camlin Fine Sciences Ltd., 2nd floor, In G.S. Point, CST Road, Kalina, Santacruz (East), Mumbai 400 098.